Treatment for the recurrence of hepatocellular carcinoma following liver transplantation: what is the best strategy?
Shi
Ying-Hong
YH
Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhou
Jian
J
Fan
Jia
J
D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery / Q000628:therapy*; D020123:Sirolimus / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D020123:Sirolimus